_id
69171f8d3c536f8df2316813
Ticker
TMCI
Name
Treace Medical Concepts Inc
Exchange
NASDAQ
Address
100 Palmetto Park Place, Ponte Vedra, FL, United States, 32081
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.treace.com
Description
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Last Close
2.91
Volume
682055
Current Price
2.8
Change
-3.7800687285223478
Last Updated
2025-12-04T14:14:05.348Z
Image
https://logo.clearbit.com/www.treace.com
Ipo Date
2021-04-23T00:00:00.000Z
Market Cap
170764432
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.51925
Sentiment Sources
4
Rating
3.5714
Target Price
5.47
Strong Buy
2
Buy
0
Hold
5
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
50214000
Cost Of Revenue
10508000
Gross Profit
39706000
Operating Expenses
55382000
Operating Income
-15676000
Interest Expense
1338000
Pretax Income
-16288000
Net Income
-16288000
Eps
-0.25644185788599333
Dividends Per Share
-
Shares Outstanding
63718073
Income Tax Expense
-
EBITDA
-12172000
Operating Margin
-31.21838531086948
Total Other Income Expense Net
-612000
Cash
7686000
Short Term Investments
49730000
Receivables
32959000
Inventories
41424000
Total Current Assets
137997000
Property Plant Equipment
37803000
Total Assets
196591000
Payables
16103000
Short Term Debt
-
Long Term Debt
53529000
Total Liabilities
107404000
Equity
89187000
Depreciation
2853000
Change In Working Capital
-812000
Cash From Operations
-9092000
Capital Expenditures
2809000
Cash From Investing
8736000
Cash From Financing
-10000
Net Change In Cash
-366000
PE
-
PB
1.9940466839337572
ROE
-18.262751297834885
ROA
-8.285221602209663
FCF
-11901000
Fcf Percent
-0.23700561596367548
Piotroski FScore
1
Health Score
25
Deep Value Investing Score
2
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
6
Net Net Investing Score
1.5
Quality Investing Score
2
Value Investing Score
5.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
50214000
Quarters > 0 > income Statement > cost Of Revenue
10508000
Quarters > 0 > income Statement > gross Profit
39706000
Quarters > 0 > income Statement > operating Expenses
55382000
Quarters > 0 > income Statement > operating Income
-15676000
Quarters > 0 > income Statement > interest Expense
1338000
Quarters > 0 > income Statement > pretax Income
-16288000
Quarters > 0 > income Statement > net Income
-16288000
Quarters > 0 > income Statement > eps
-0.25644185788599333
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
63515372
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-12172000
Quarters > 0 > income Statement > operating Margin
-31.21838531086948
Quarters > 0 > income Statement > total Other Income Expense Net
-612000
Quarters > 0 > balance Sheet > cash
7686000
Quarters > 0 > balance Sheet > short Term Investments
49730000
Quarters > 0 > balance Sheet > receivables
32959000
Quarters > 0 > balance Sheet > inventories
41424000
Quarters > 0 > balance Sheet > total Current Assets
137997000
Quarters > 0 > balance Sheet > property Plant Equipment
37803000
Quarters > 0 > balance Sheet > total Assets
196591000
Quarters > 0 > balance Sheet > payables
16103000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
53529000
Quarters > 0 > balance Sheet > total Liabilities
107404000
Quarters > 0 > balance Sheet > equity
89187000
Quarters > 0 > cash Flow > net Income
-16288000
Quarters > 0 > cash Flow > depreciation
2853000
Quarters > 0 > cash Flow > change In Working Capital
-812000
Quarters > 0 > cash Flow > cash From Operations
-9092000
Quarters > 0 > cash Flow > capital Expenditures
2809000
Quarters > 0 > cash Flow > cash From Investing
8736000
Quarters > 0 > cash Flow > cash From Financing
-10000
Quarters > 0 > cash Flow > net Change In Cash
-366000
Quarters > 0 > ratios > PE
-0.25644185788599333
Quarters > 0 > ratios > PB
1.9940466839337572
Quarters > 0 > ratios > ROE
-18.262751297834885
Quarters > 0 > ratios > ROA
-8.285221602209663
Quarters > 0 > ratios > FCF
-11901000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-0.23700561596367548
Quarters > 0 > health Score
25
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
47387000
Quarters > 1 > income Statement > cost Of Revenue
9635000
Quarters > 1 > income Statement > gross Profit
37752000
Quarters > 1 > income Statement > operating Expenses
54726000
Quarters > 1 > income Statement > operating Income
-16974000
Quarters > 1 > income Statement > interest Expense
1321000
Quarters > 1 > income Statement > pretax Income
-17398000
Quarters > 1 > income Statement > net Income
-17398000
Quarters > 1 > income Statement > eps
-0.276128526957472
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
63006891
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-13501000
Quarters > 1 > income Statement > operating Margin
-35.81995061936818
Quarters > 1 > income Statement > total Other Income Expense Net
-424000
Quarters > 1 > balance Sheet > cash
8052000
Quarters > 1 > balance Sheet > short Term Investments
61237000
Quarters > 1 > balance Sheet > receivables
30333000
Quarters > 1 > balance Sheet > inventories
42397000
Quarters > 1 > balance Sheet > total Current Assets
147602000
Quarters > 1 > balance Sheet > property Plant Equipment
37750000
Quarters > 1 > balance Sheet > total Assets
206443000
Quarters > 1 > balance Sheet > payables
19959000
Quarters > 1 > balance Sheet > short Term Debt
3203000
Quarters > 1 > balance Sheet > long Term Debt
53454000
Quarters > 1 > balance Sheet > total Liabilities
108828000
Quarters > 1 > balance Sheet > equity
97615000
Quarters > 1 > cash Flow > net Income
-17398000
Quarters > 1 > cash Flow > depreciation
2462000
Quarters > 1 > cash Flow > change In Working Capital
1490000
Quarters > 1 > cash Flow > cash From Operations
-3050000
Quarters > 1 > cash Flow > capital Expenditures
4767000
Quarters > 1 > cash Flow > cash From Investing
-3257000
Quarters > 1 > cash Flow > cash From Financing
987000
Quarters > 1 > cash Flow > net Change In Cash
-5320000
Quarters > 1 > ratios > PE
-0.276128526957472
Quarters > 1 > ratios > PB
1.807296980996773
Quarters > 1 > ratios > ROE
-17.823080469190185
Quarters > 1 > ratios > ROA
-8.427507835092495
Quarters > 1 > ratios > FCF
-7817000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.1649608542427248
Quarters > 1 > health Score
25
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
52570000
Quarters > 2 > income Statement > cost Of Revenue
10677000
Quarters > 2 > income Statement > gross Profit
41893000
Quarters > 2 > income Statement > operating Expenses
57475000
Quarters > 2 > income Statement > operating Income
-15582000
Quarters > 2 > income Statement > interest Expense
1311000
Quarters > 2 > income Statement > pretax Income
-15922000
Quarters > 2 > income Statement > net Income
-15922000
Quarters > 2 > income Statement > eps
-0.2540956323590804
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
62661447
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-12150000
Quarters > 2 > income Statement > operating Margin
-29.640479360852197
Quarters > 2 > income Statement > total Other Income Expense Net
-340000
Quarters > 2 > balance Sheet > cash
13372000
Quarters > 2 > balance Sheet > short Term Investments
62717000
Quarters > 2 > balance Sheet > receivables
31110000
Quarters > 2 > balance Sheet > inventories
37940000
Quarters > 2 > balance Sheet > total Current Assets
149437000
Quarters > 2 > balance Sheet > property Plant Equipment
35370000
Quarters > 2 > balance Sheet > total Assets
205846000
Quarters > 2 > balance Sheet > payables
13223000
Quarters > 2 > balance Sheet > short Term Debt
2076000
Quarters > 2 > balance Sheet > long Term Debt
53380000
Quarters > 2 > balance Sheet > total Liabilities
100505000
Quarters > 2 > balance Sheet > equity
105341000
Quarters > 2 > cash Flow > net Income
-15922000
Quarters > 2 > cash Flow > depreciation
2461000
Quarters > 2 > cash Flow > change In Working Capital
7704000
Quarters > 2 > cash Flow > cash From Operations
4198000
Quarters > 2 > cash Flow > capital Expenditures
3543000
Quarters > 2 > cash Flow > cash From Investing
-1894000
Quarters > 2 > cash Flow > cash From Financing
-282000
Quarters > 2 > cash Flow > net Change In Cash
2022000
Quarters > 2 > ratios > PE
-0.2540956323590804
Quarters > 2 > ratios > PB
1.6655628065045898
Quarters > 2 > ratios > ROE
-15.114722662591015
Quarters > 2 > ratios > ROA
-7.734908621007938
Quarters > 2 > ratios > FCF
655000
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
0.012459577705915922
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
68708000
Quarters > 3 > income Statement > cost Of Revenue
13231000
Quarters > 3 > income Statement > gross Profit
55477000
Quarters > 3 > income Statement > operating Expenses
55681000
Quarters > 3 > income Statement > operating Income
-204000
Quarters > 3 > income Statement > interest Expense
1314000
Quarters > 3 > income Statement > pretax Income
-501000
Quarters > 3 > income Statement > net Income
-501000
Quarters > 3 > income Statement > eps
-0.00803649589337466
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
62340603
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
3050000
Quarters > 3 > income Statement > operating Margin
-0.29690865692495777
Quarters > 3 > income Statement > total Other Income Expense Net
-297000
Quarters > 3 > balance Sheet > cash
11350000
Quarters > 3 > balance Sheet > short Term Investments
64327000
Quarters > 3 > balance Sheet > receivables
40803000
Quarters > 3 > balance Sheet > inventories
39255000
Quarters > 3 > balance Sheet > total Current Assets
161402000
Quarters > 3 > balance Sheet > property Plant Equipment
34395000
Quarters > 3 > balance Sheet > total Assets
217094000
Quarters > 3 > balance Sheet > payables
10522000
Quarters > 3 > balance Sheet > short Term Debt
413000
Quarters > 3 > balance Sheet > long Term Debt
53306000
Quarters > 3 > balance Sheet > total Liabilities
104202000
Quarters > 3 > balance Sheet > equity
112892000
Quarters > 3 > cash Flow > net Income
-501000
Quarters > 3 > cash Flow > depreciation
2237000
Quarters > 3 > cash Flow > change In Working Capital
-17012000
Quarters > 3 > cash Flow > cash From Operations
-4207000
Quarters > 3 > cash Flow > capital Expenditures
3074000
Quarters > 3 > cash Flow > cash From Investing
3421000
Quarters > 3 > cash Flow > cash From Financing
26000
Quarters > 3 > cash Flow > net Change In Cash
-760000
Quarters > 3 > ratios > PE
-0.00803649589337466
Quarters > 3 > ratios > PB
1.5462006909258406
Quarters > 3 > ratios > ROE
-0.4437869822485207
Quarters > 3 > ratios > ROA
-0.23077560872248887
Quarters > 3 > ratios > FCF
-7281000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-0.10597019269954008
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
209357000
Annuals > 0 > income Statement > cost Of Revenue
41093000
Annuals > 0 > income Statement > gross Profit
168264000
Annuals > 0 > income Statement > operating Expenses
223952000
Annuals > 0 > income Statement > operating Income
-55688000
Annuals > 0 > income Statement > interest Expense
5256000
Annuals > 0 > income Statement > pretax Income
-55743000
Annuals > 0 > income Statement > net Income
-55743000
Annuals > 0 > income Statement > eps
-0.8974588935152779
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
62112037
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-42068000
Annuals > 0 > income Statement > operating Margin
-26.599540497809958
Annuals > 0 > income Statement > total Other Income Expense Net
-55000
Annuals > 0 > balance Sheet > cash
11350000
Annuals > 0 > balance Sheet > short Term Investments
64327000
Annuals > 0 > balance Sheet > receivables
40803000
Annuals > 0 > balance Sheet > inventories
39255000
Annuals > 0 > balance Sheet > total Current Assets
161402000
Annuals > 0 > balance Sheet > property Plant Equipment
34395000
Annuals > 0 > balance Sheet > total Assets
217094000
Annuals > 0 > balance Sheet > payables
10522000
Annuals > 0 > balance Sheet > short Term Debt
413000
Annuals > 0 > balance Sheet > long Term Debt
53306000
Annuals > 0 > balance Sheet > total Liabilities
104202000
Annuals > 0 > balance Sheet > equity
112892000
Annuals > 0 > cash Flow > net Income
-55743000
Annuals > 0 > cash Flow > depreciation
8419000
Annuals > 0 > cash Flow > change In Working Capital
-25433000
Annuals > 0 > cash Flow > cash From Operations
-37167000
Annuals > 0 > cash Flow > capital Expenditures
11593000
Annuals > 0 > cash Flow > cash From Investing
35375000
Annuals > 0 > cash Flow > cash From Financing
160000
Annuals > 0 > cash Flow > net Change In Cash
-1632000
Annuals > 0 > ratios > PE
-0.8974588935152779
Annuals > 0 > ratios > PB
1.4745089037309995
Annuals > 0 > ratios > ROE
-49.37728094107643
Annuals > 0 > ratios > ROA
-25.676895722590213
Annuals > 0 > ratios > FCF
-48760000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.2329036048472227
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
187118000
Annuals > 1 > income Statement > cost Of Revenue
35181000
Annuals > 1 > income Statement > gross Profit
151937000
Annuals > 1 > income Statement > operating Expenses
203365000
Annuals > 1 > income Statement > operating Income
-51428000
Annuals > 1 > income Statement > interest Expense
5167000
Annuals > 1 > income Statement > pretax Income
-49527000
Annuals > 1 > income Statement > net Income
-49527000
Annuals > 1 > income Statement > eps
-0.8138906769658586
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
60852153
Annuals > 1 > income Statement > income Tax Expense
5184105
Annuals > 1 > income Statement > EBITDA
-39008000
Annuals > 1 > income Statement > operating Margin
-27.4842612682906
Annuals > 1 > income Statement > total Other Income Expense Net
1901000
Annuals > 1 > balance Sheet > cash
12982000
Annuals > 1 > balance Sheet > short Term Investments
110216000
Annuals > 1 > balance Sheet > receivables
38063000
Annuals > 1 > balance Sheet > inventories
29245000
Annuals > 1 > balance Sheet > total Current Assets
198359000
Annuals > 1 > balance Sheet > property Plant Equipment
31562000
Annuals > 1 > balance Sheet > total Assets
251907000
Annuals > 1 > balance Sheet > payables
11835000
Annuals > 1 > balance Sheet > short Term Debt
1404000
Annuals > 1 > balance Sheet > long Term Debt
53008000
Annuals > 1 > balance Sheet > total Liabilities
113969000
Annuals > 1 > balance Sheet > equity
137938000
Annuals > 1 > cash Flow > net Income
-49527000
Annuals > 1 > cash Flow > depreciation
5352000
Annuals > 1 > cash Flow > change In Working Capital
-9743000
Annuals > 1 > cash Flow > cash From Operations
-34575000
Annuals > 1 > cash Flow > capital Expenditures
11458000
Annuals > 1 > cash Flow > cash From Investing
-81299000
Annuals > 1 > cash Flow > cash From Financing
109383000
Annuals > 1 > cash Flow > net Change In Cash
-6491000
Annuals > 1 > ratios > PE
-0.8138906769658586
Annuals > 1 > ratios > PB
1.1822976267598486
Annuals > 1 > ratios > ROE
-35.905261784279894
Annuals > 1 > ratios > ROA
-19.660827210041802
Annuals > 1 > ratios > FCF
-46033000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.2460105388043908
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
141838000
Annuals > 2 > income Statement > cost Of Revenue
27523000
Annuals > 2 > income Statement > gross Profit
114315000
Annuals > 2 > income Statement > operating Expenses
149159000
Annuals > 2 > income Statement > operating Income
-34844000
Annuals > 2 > income Statement > interest Expense
4398000
Annuals > 2 > income Statement > pretax Income
-42815000
Annuals > 2 > income Statement > net Income
-42815000
Annuals > 2 > income Statement > eps
-0.7745559378454996
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
55276834
Annuals > 2 > income Statement > income Tax Expense
4483000
Annuals > 2 > income Statement > EBITDA
-36284000
Annuals > 2 > income Statement > operating Margin
-24.56605423088312
Annuals > 2 > income Statement > total Other Income Expense Net
-7971000
Annuals > 2 > balance Sheet > cash
19473000
Annuals > 2 > balance Sheet > short Term Investments
61779000
Annuals > 2 > balance Sheet > receivables
29196000
Annuals > 2 > balance Sheet > inventories
19330000
Annuals > 2 > balance Sheet > total Current Assets
133402000
Annuals > 2 > balance Sheet > property Plant Equipment
25476000
Annuals > 2 > balance Sheet > total Assets
159024000
Annuals > 2 > balance Sheet > payables
8668000
Annuals > 2 > balance Sheet > short Term Debt
339000
Annuals > 2 > balance Sheet > long Term Debt
52711000
Annuals > 2 > balance Sheet > total Liabilities
98495000
Annuals > 2 > balance Sheet > equity
60529000
Annuals > 2 > cash Flow > net Income
-42815000
Annuals > 2 > cash Flow > depreciation
2133000
Annuals > 2 > cash Flow > change In Working Capital
-5809000
Annuals > 2 > cash Flow > cash From Operations
-30648000
Annuals > 2 > cash Flow > capital Expenditures
14838000
Annuals > 2 > cash Flow > cash From Investing
-76518000
Annuals > 2 > cash Flow > cash From Financing
20806000
Annuals > 2 > cash Flow > net Change In Cash
-86360000
Annuals > 2 > ratios > PE
-0.7745559378454996
Annuals > 2 > ratios > PB
2.447453536651853
Annuals > 2 > ratios > ROE
-70.73468915726346
Annuals > 2 > ratios > ROA
-26.923609014991445
Annuals > 2 > ratios > FCF
-45486000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.32068980104062383
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
94419000
Annuals > 3 > income Statement > cost Of Revenue
16888000
Annuals > 3 > income Statement > gross Profit
77531000
Annuals > 3 > income Statement > operating Expenses
94041000
Annuals > 3 > income Statement > operating Income
-16510000
Annuals > 3 > income Statement > interest Expense
4060000
Annuals > 3 > income Statement > pretax Income
-20552000
Annuals > 3 > income Statement > net Income
-20552000
Annuals > 3 > income Statement > eps
-0.379320590164663
Annuals > 3 > income Statement > dividends Per Share
7935000
Annuals > 3 > income Statement > shares Outstanding
54181082
Annuals > 3 > income Statement > income Tax Expense
4060000
Annuals > 3 > income Statement > EBITDA
-15807000
Annuals > 3 > income Statement > operating Margin
-17.48588737436321
Annuals > 3 > income Statement > total Other Income Expense Net
-4042000
Annuals > 3 > balance Sheet > cash
105833000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
18568000
Annuals > 3 > balance Sheet > inventories
10561000
Annuals > 3 > balance Sheet > total Current Assets
137972000
Annuals > 3 > balance Sheet > property Plant Equipment
2849000
Annuals > 3 > balance Sheet > total Assets
140821000
Annuals > 3 > balance Sheet > payables
4056000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
29365000
Annuals > 3 > balance Sheet > total Liabilities
47748000
Annuals > 3 > balance Sheet > equity
93073000
Annuals > 3 > cash Flow > net Income
-20552000
Annuals > 3 > cash Flow > depreciation
685000
Annuals > 3 > cash Flow > change In Working Capital
-1330000
Annuals > 3 > cash Flow > cash From Operations
-17193000
Annuals > 3 > cash Flow > capital Expenditures
2705000
Annuals > 3 > cash Flow > cash From Investing
-2705000
Annuals > 3 > cash Flow > cash From Financing
107652000
Annuals > 3 > cash Flow > net Change In Cash
87754000
Annuals > 3 > ratios > PE
-0.379320590164663
Annuals > 3 > ratios > PB
1.560122696807882
Annuals > 3 > ratios > ROE
-22.081591868748188
Annuals > 3 > ratios > ROA
-14.594414185384283
Annuals > 3 > ratios > FCF
-19898000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.2107414821169468
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.25644185788599333
Valuation > metrics > PB
1.9940466839337572
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-18.262751297834885
Profitability > metrics > ROA
-11.803155141053791
Profitability > metrics > Net Margin
-0.3243716891703509
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.2042562256831153
Risk > metrics > Interest Coverage
-11.715994020926756
Risk > final Score
-17
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.569645407688009
Liquidity > metrics > Quick Ratio
5.9972054896603115
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-21
Prev Risks > 1
0
Prev Risks > 2
47
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:29:58.431Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0239
Earnings History > 0 > eps Difference
0.0239
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.26
Earnings History > 1 > eps Estimate
-0.28
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
7.1429
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-07
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.28
Earnings History > 2 > eps Estimate
-0.29
Earnings History > 2 > eps Difference
0.01
Earnings History > 2 > surprise Percent
3.4483
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2468
Earnings History > 3 > eps Estimate
-0.3022
Earnings History > 3 > eps Difference
0.0554
Earnings History > 3 > surprise Percent
18.3322
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-02-25
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0016
Earnings History > 4 > eps Estimate
-0.0427
Earnings History > 4 > eps Difference
0.0411
Earnings History > 4 > surprise Percent
96.2529
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-05
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.25
Earnings History > 5 > eps Estimate
-0.27
Earnings History > 5 > eps Difference
0.02
Earnings History > 5 > surprise Percent
7.4074
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.29
Earnings History > 6 > eps Estimate
-0.29
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
0
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.3
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
0
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-02-27
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.1
Earnings History > 8 > eps Estimate
-0.09
Earnings History > 8 > eps Difference
-0.01
Earnings History > 8 > surprise Percent
-11.1111
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-09
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.28
Earnings History > 9 > eps Estimate
-0.26
Earnings History > 9 > eps Difference
-0.02
Earnings History > 9 > surprise Percent
-7.6923
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-08
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.2
Earnings History > 10 > eps Estimate
-0.24
Earnings History > 10 > eps Difference
0.04
Earnings History > 10 > surprise Percent
16.6667
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-08
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.23
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-07
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.08
Earnings History > 12 > eps Estimate
-0.14
Earnings History > 12 > eps Difference
0.06
Earnings History > 12 > surprise Percent
42.8571
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.22
Earnings History > 13 > eps Estimate
-0.29
Earnings History > 13 > eps Difference
0.07
Earnings History > 13 > surprise Percent
24.1379
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.31
Earnings History > 14 > eps Estimate
-0.2
Earnings History > 14 > eps Difference
-0.11
Earnings History > 14 > surprise Percent
-55
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-05
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.16
Earnings History > 15 > eps Estimate
-0.2
Earnings History > 15 > eps Difference
0.04
Earnings History > 15 > surprise Percent
20
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-03
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.12
Earnings History > 16 > eps Estimate
-0.0058
Earnings History > 16 > eps Difference
-0.1142
Earnings History > 16 > surprise Percent
-1968.9655
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-04
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.12
Earnings History > 17 > eps Estimate
-0.12
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
0
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-05
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.1
Earnings History > 18 > eps Estimate
-0.12
Earnings History > 18 > eps Difference
0.02
Earnings History > 18 > surprise Percent
16.6667
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-25
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.07
Earnings History > 19 > eps Estimate
-0.06
Earnings History > 19 > eps Difference
-0.01
Earnings History > 19 > surprise Percent
-16.6667
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-03
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.06
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.06
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.0476
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.0476
Earnings History > 21 > surprise Percent
-
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Reduce" from Brokerages MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$5.47
Analyst Picks
Strong Buy
2
Buy
0
Hold
5
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Medium
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 67.54% of the total shares of Treace Medical Concepts Inc
1.
Armistice Capital, LLC(9.9093%)
since
2025/06/30
2.
BlackRock Inc(5.9624%)
since
2025/06/30
3.
William Blair Investment Management, LLC(4.907%)
since
2025/06/30
4.
Vanguard Group Inc(4.3139%)
since
2025/06/30
5.
Gagnon Securities LLC(3.5619%)
since
2025/06/30
6.
JPMorgan Chase & Co(2.8132%)
since
2025/06/30
7.
Atlantic Trust Group, LLC(2.6713%)
since
2025/06/30
8.
Millennium Management LLC(2.4017%)
since
2025/06/30
9.
Vanguard Total Stock Mkt Idx Inv(2.2589%)
since
2025/07/31
10.
iShares Russell 2000 ETF(1.8287%)
since
2025/08/31
11.
Geode Capital Management, LLC(1.7722%)
since
2025/06/30
12.
William Blair Small Cap Growth I(1.6925%)
since
2025/07/31
13.
Morgan Stanley - Brokerage Accounts(1.6137%)
since
2025/06/30
14.
State Street Corp(1.5608%)
since
2025/06/30
15.
Deutsche Bank AG(1.4651%)
since
2025/06/30
16.
First Eagle Small Cap Opportunity I(1.4525%)
since
2025/07/31
17.
Arnhold & S. Bleichroeder Advisers, LLC(1.4374%)
since
2025/06/30
18.
Parkman Healthcare Partners LLC(1.336%)
since
2025/06/30
19.
Gagnon Advisors, LLC(1.3143%)
since
2025/06/30
20.
D. E. Shaw & Co LP(1.3033%)
since
2025/06/30
21.
First Eagle US Small Cap Strategy(1.2619%)
since
2025/06/30
22.
Xtrackers MSCI World Swap ETF 1C(1.2481%)
since
2025/07/31
23.
CenterBook Partners LP(0.8907%)
since
2025/06/30
24.
JPMorgan US Small Company L(0.8654%)
since
2025/07/31
25.
Vanguard Institutional Extnd Mkt Idx Tr(0.767%)
since
2025/07/31
26.
Fidelity Small Cap Index(0.758%)
since
2025/06/30
27.
Northern Trust Corp(0.6886%)
since
2025/06/30
28.
iShares Russell 2000 Growth ETF(0.6823%)
since
2025/08/31
29.
UBS Group AG(0.5975%)
since
2025/06/30
30.
Kornitzer Capital Management Inc(0.5784%)
since
2025/06/30
31.
Kornitzer Small Cap Equity(0.5784%)
since
2025/03/31
32.
Buffalo Small Cap Growth(0.5784%)
since
2025/06/30
33.
Fidelity Extended Market Index(0.3725%)
since
2025/07/31
34.
Vanguard Russell 2000 ETF(0.3589%)
since
2025/07/31
35.
iShares US Medical Devices ETF(0.346%)
since
2025/08/31
36.
Schwab US Small-Cap ETF™(0.3226%)
since
2025/08/30
37.
Paradigm Micro-Cap(0.3166%)
since
2025/08/31
38.
State St Russell Sm Cap® Indx SL Cl I(0.2706%)
since
2025/08/31
39.
Vanguard Health Care ETF(0.2447%)
since
2025/07/31
40.
William Blair Small Cap Growth CIT 3(0.241%)
since
2025/07/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0239
Date
2025-09-30
EPS Actual
-0.26
EPS Estimate
-0.28
EPS Difference
0.02
Surprise Percent
7.1429%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.